Allogeneic NK-92 Cells: Advancing from Pre-Clinical Development to Clinical Application

Time: 10:00 am
day: Day One

Details:

  • Recapping the pre-clinical development of NK-92 and its clonal ‘offsprings’
  • Showcasing the outcome of first clinical studies
  • Reviewing novel NK-92 based variants expressing FcR, CARs and immune modulators

Speakers: